CASSIARIN A

ID: ALA596396

Max Phase: Preclinical

Molecular Formula: C13H11NO2

Molecular Weight: 213.24

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1=Cc2nc(C)cc3cc(O)cc(c23)O1

Standard InChI:  InChI=1S/C13H11NO2/c1-7-3-9-5-10(15)6-12-13(9)11(14-7)4-8(2)16-12/h3-6,15H,1-2H3

Standard InChI Key:  PEFIRMBVFBVVGZ-UHFFFAOYSA-N

Associated Targets(Human)

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

BT-474 2113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SW-620 52400 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum 966862 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Aorta 2975 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Calf thymus DNA 4845 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 213.24Molecular Weight (Monoisotopic): 213.0790AlogP: 3.00#Rotatable Bonds: 0
Polar Surface Area: 42.35Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.64CX Basic pKa: 6.39CX LogP: 1.86CX LogD: 1.78
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.73Np Likeness Score: 1.19

References

1. Morita H, Tomizawa Y, Deguchi J, Ishikawa T, Arai H, Zaima K, Hosoya T, Hirasawa Y, Matsumoto T, Kamata K, Ekasari W, Widyawaruyanti A, Wahyuni TS, Zaini NC, Honda T..  (2009)  Synthesis and structure-activity relationships of cassiarin A as potential antimalarials with vasorelaxant activity.,  17  (24): [PMID:19892554] [10.1016/j.bmc.2009.10.013]
2. Oshimi S, Deguchi J, Hirasawa Y, Ekasari W, Widyawaruyanti A, Wahyuni TS, Zaini NC, Shirota O, Morita H..  (2009)  Cassiarins C-E, antiplasmodial alkaloids from the flowers of Cassia siamea.,  72  (10): [PMID:19754128] [10.1021/np9004213]
3. Luesakul U, Palaga T, Krusong K, Ngamrojanavanich N, Vilaivan T, Puthong S, Muangsin N..  (2014)  Synthesis, cytotoxicity, DNA binding and topoisomerase II inhibition of cassiarin A derivatives.,  24  (13): [PMID:24835201] [10.1016/j.bmcl.2014.04.107]

Source